Stock listing

Lang & Schwarz:A0D9T1 DexCom, Inc. Aktie

German listing (Lang & Schwarz) of DexCom, Inc. · home listing NASDAQ:DXCM

Follow DexCom, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:DXCM

$79.32 USD -3.20 (-3.9%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:DXCM

Past year +35.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$78.75 – $81.58 USDNov 20, 2026
Volume
4.61M sharesNov 20, 2026
Market cap
$29.58B USDAt the close on Nov 20, 2026 · price × 373.0M shares outstanding
52-week range
$56.72 – $92.59 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$354.1M USDMedian day 3.61M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
DexCom, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:DXCM · Home$79.32 USD-3.20 (-3.9%)4,607,800$80.48$81.58$78.75$82.52Close on Nov 20, 2026
B3:D1EX349.30 BRL0.00 (0.0%)—9.309.309.309.30Close on Nov 19, 2026
Frankfurt:DC4€72.00 EUR-1.20 (-1.6%)122€72.80€73.40€72.00€73.20Close on Nov 20, 2026
Munich:DC4€72.80 EUR-3.00 (-4.0%)—€73.30€73.30€72.80€75.80Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:DXCM · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$79.32-3.20-3.9%$80.48$81.58$78.754,607,800
$82.52+0.48+0.6%$81.67$83.07$81.284,250,208
$82.04+0.43+0.5%$82.21$84.02$81.564,583,543
$81.61-1.72-2.1%$83.46$83.75$81.454,375,546
$83.33+1.94+2.4%$82.01$83.66$81.393,013,567
$81.39+1.045+1.3%$80.99$82.51$79.384,087,099
$80.35+0.425+0.5%$79.80$80.58$78.933,231,195
$79.92-1.15-1.4%$80.88$81.07$79.183,098,705
$81.07+1.66+2.1%$80.48$81.45$79.314,098,909
$79.41-5.05-6.0%$82.73$82.85$79.213,936,995
$84.46-4.02-4.5%$89.58$90.25$83.334,899,646
$88.48+5.51+6.6%$85.06$88.96$84.754,822,585
$82.97-1.79-2.1%$84.55$85.18$82.814,123,104
$84.76+2.47+3.0%$82.82$85.19$82.584,059,519
$82.29+2.36+3.0%$81.52$85.25$79.798,637,191
$79.93+1.31+1.7%$79.08$80.01$78.595,911,426
$78.62+0.06+0.1%$78.19$79.41$77.695,370,036
$78.56-0.010.0%$78.62$79.86$78.055,159,367
$78.57+0.63+0.8%$77.25$78.58$76.526,026,136
$77.94-0.38-0.5%$78.68$79.51$77.825,214,998
$78.32-1.94-2.4%$79.90$80.49$77.1110,794,300
$80.26-5.48-6.4%$83.75$86.17$79.928,018,713
$85.74-0.24-0.3%$86.11$87.08$85.142,393,137
$85.98-0.06-0.1%$86.11$86.61$85.432,590,519
$86.04-1.67-1.9%$87.93$88.87$85.803,583,400
$87.71+4.24+5.1%$85.48$87.88$85.254,786,100
$83.47-1.59-1.9%$85.89$86.18$83.303,479,900
$85.06-0.86-1.0%$86.19$86.60$84.494,017,000
$85.92+1.81+2.2%$84.60$86.10$84.212,991,800
$84.11-0.30-0.4%$84.41$85.49$82.943,154,200
$84.41+0.11+0.1%$84.01$84.54$83.083,607,100
$84.30+0.91+1.1%$83.81$85.70$83.742,863,800
$83.39-3.51-4.0%$86.28$86.75$82.863,574,700
$86.90+1.54+1.8%$84.75$87.12$84.753,078,900
$85.36-0.87-1.0%$86.67$86.67$84.802,204,400
$86.23-0.06-0.1%$86.46$87.70$85.813,034,600
$86.29-0.35-0.4%$86.21$86.75$85.263,474,500
$86.64-0.040.0%$86.63$87.03$85.243,120,500
$86.68+0.06+0.1%$86.87$87.34$85.273,411,300
$86.62-0.85-1.0%$87.38$87.64$86.361,891,000
$87.47-0.26-0.3%$87.68$88.00$86.882,141,700
$87.73-1.80-2.0%$89.50$90.05$87.363,668,500
$89.53+0.36+0.4%$89.12$90.39$88.187,296,000
$89.17-0.18-0.2%$88.83$89.68$88.333,515,900
$89.35+1.42+1.6%$87.83$89.92$87.3914,573,000
$87.93+0.59+0.7%$87.54$88.26$87.172,824,000
$87.34+0.89+1.0%$86.05$88.79$86.053,616,800
$86.45+1.77+2.1%$84.04$87.36$83.265,960,900
$84.68+1.65+2.0%$83.92$84.98$83.762,540,900
$83.03-1.48-1.8%$84.65$85.82$82.832,547,400
$84.51+0.63+0.8%$83.27$84.82$82.293,539,800
$83.88-0.65-0.8%$83.93$85.16$82.804,177,200
$84.53-3.37-3.8%$86.59$86.75$84.248,224,100
$87.90-1.81-2.0%$88.78$89.00$87.652,361,500
$89.71+0.020.0%$89.73$91.00$89.051,677,900
$89.69-0.45-0.5%$90.03$91.90$89.541,918,200
$90.14-0.92-1.0%$90.83$92.34$89.912,151,600
$91.06+0.24+0.3%$90.00$91.18$89.092,999,300
$90.82+1.53+1.7%$89.81$90.84$88.832,546,700
$89.29+0.33+0.4%$88.37$90.43$87.603,025,900
$88.96-0.20-0.2%$88.17$89.76$87.513,822,600
$89.16-1.90-2.1%$90.73$91.14$88.784,105,700
$91.06-1.28-1.4%$92.30$92.59$91.034,451,300
$92.34+2.12+2.3%$89.61$92.56$89.203,481,300
$90.22+0.34+0.4%$89.42$91.39$89.285,164,500

Splits

1 split · NASDAQ:DXCM · every price before a split is adjusted for it

DayRatioWhat
4-for-1Split
Ticker
Lang & Schwarz:A0D9T1
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Latest news

All DexCom, Inc. news

DexCom, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
36 in the last 12 months · 213 in all · newest Nov 19, 2026 · oldest 2019
Calls
32 calls with a replay · 32 with a transcript · latest Oct 29, 2026
Decks
45 decks · latest Oct 29, 2026

Where DexCom, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:DXCM · Home listingNASDAQUnited StatesUSD
gettex:DC4gettexGermanyEUR
LS Exchange:A0D9T1LS ExchangeGermanyEUR
Tradegate:DC4TradegateGermanyEUR
BMV:DXCMBMVMexicoMXN
Lang & Schwarz:A0D9T1 · This pageLang & SchwarzGermanyEUR
Dusseldorf:DC4DusseldorfGermanyEUR
B3:D1EX34B3BrazilBRL
Frankfurt:DC4FrankfurtGermanyEUR
BOATS:DXCMBOATSUnited StatesUSD
Milan:1DXCMMilanItalyEUR
LSE:0A4MLSEUnited KingdomUSD
Munich:DC4MunichGermanyEUR
VIE:DXCMViennaAustriaEUR
Hanover:DC4HanoverGermanyEUR
Hamburg:DC4HamburgGermanyEUR
Stuttgart:DC4StuttgartGermanyEUR
Turquoise:DXCMNTurquoiseUnited KingdomUSD
BIVA:DXCMBIVAMexicoMXN
BX Swiss:DC4BX SwissSwitzerlandCHF
SIX Swiss:DXCMSIX SwissSwitzerlandCHF
SIX Swiss:DXCM.USDSIX SwissSwitzerlandUSD
Xetra:DC4XetraGermanyEUR

Valuation

P/E 29.9× against a median of 27.9×: 7th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$28.62B USD
P/E
29.9×
EV/sales
5.6×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
11.7×
Gross margin
63.4%
Operating margin
24.0%
Net margin
19.4%
Debt to equity
0.0×
Beta vs S&P 500
0.71

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
DexCom, Inc. · NASDAQ:DXCMUS$29.58BUS$28.62B29.9×5.6×n/a11.7×19.4%0.0×0.71
Siemens Healthineers AG · XETR:SHLUS$52.77BUS$49.52B21.7×1.9×10.3×2.4×9.4%0.0×n/a
GE HealthCare Technologies Inc. · NASDAQ:GEHCUS$36.46BUS$43.61B16.9×2.0×13.7×3.1×10.0%0.9×0.65
Alcon AG · SIX:ALCUS$35.86BUS$38.74B54.0×3.5×16.1×1.6×6.1%0.2×n/a
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A · SZSE:300760US$33.43BUS$30.45B28.7×5.9×n/a5.4×22.4%0.0×n/a
ResMed Inc. · NYSE:RMDUS$33.14BUS$32.54B20.8×5.7×15.6×5.6×27.8%0.1×0.48
Koninklijke Philips N.V. · EURONEXT:PHIAUS$28.31BUS$34.23B27.0×1.8×10.0×2.2×5.4%0.7×n/a
STERIS plc (Ireland) · NYSE:STEUS$24.94BUS$26.30B30.2×4.3×15.8×3.4×13.4%0.3×0.40
Sonova Holding AG · SIX:SOONUS$20.69BUS$21.87B40.4×5.1×19.6×6.7×11.9%0.7×n/a
Straumann Holding AG · SIX:STMNUS$20.27BUS$20.39B47.8×6.6×24.6×7.5×13.7%0.2×n/a
Zimmer Biomet Holdings, Inc. · NYSE:ZBHUS$19.13BUS$26.24B24.9×3.1×11.6×1.5×8.9%0.6×0.40
Median of the othersUS$30.73BUS$31.50B27.9×3.9×15.6×3.3×10.9%0.2×0.44

Forecasts

22 strong buy · 4 buy · 3 hold · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
98.58 USD · Analysts' mean
EPS, year to Dec 2026
2.70 · 25 analysts
Revenue, year to Dec 2026
5.23B · 27 analysts

Team and board

Officers

OfficerRole
Jacob LeachPresident & Chief Executive Officer
Jereme SylvainEVP, Chief Operating Officer and Chief Financial Officer
Michael BrownEVP, Chief Legal & Compliance Officer
Sean ChristensenINVESTOR RELATIONS
Jon ColemanEVP, Chief Commercial Officer
Matthew DolanEVP, Strategy & Corporate Development
Peter SimpsonEVP, Chief Technology Officer
Sadie SternEVP, Chief People & Culture Officer

Events

Calls

CallWhenStatus
DexCom (NASDAQ:DXCM) Q3 2026 Earnings CallThu, Oct 29, 2026 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2026 Earnings CallThu, Jul 30, 2026 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q1 2026 Earnings CallThu, Apr 30, 2026 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2025 Earnings CallThu, Feb 12, 2026 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q3 2025 Earnings CallThu, Oct 30, 2025 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2025 Earnings CallWed, Jul 30, 2025 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q1 2025 Earnings CallThu, May 01, 2025 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2024 Earnings CallThu, Feb 13, 2025 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q3 2024 Earnings CallThu, Oct 24, 2024 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2024 Earnings CallThu, Jul 25, 2024 · 4:30 PM ETReplay
All 32 calls
CallWhenStatus
DexCom (NASDAQ:DXCM) Q1 2024 Earnings CallThu, Apr 25, 2024 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2023 Earnings CallThu, Feb 08, 2024 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q3 2023 Earnings CallThu, Oct 26, 2023 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2023 Earnings CallThu, Jul 27, 2023 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q1 2023 Earnings CallThu, Apr 27, 2023 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2022 Earnings CallThu, Feb 09, 2023 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q3 2022 Earnings CallThu, Oct 27, 2022 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2022 Earnings CallThu, Jul 28, 2022 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q1 2022 Earnings CallThu, Apr 28, 2022 · 5:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2021 Earnings CallThu, Feb 10, 2022 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q3 2021 Earnings CallThu, Oct 28, 2021 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2021 Earnings CallThu, Jul 29, 2021 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q1 2021 Earnings CallThu, Apr 29, 2021 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2020 Earnings CallThu, Feb 11, 2021 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q3 2020 Earnings CallTue, Oct 27, 2020 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2020 Earnings CallTue, Jul 28, 2020 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q1 2020 Earnings CallTue, Apr 28, 2020 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2019 Earnings CallThu, Feb 13, 2020 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q3 2019 Earnings CallWed, Nov 06, 2019 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q2 2019 Earnings CallWed, Jul 31, 2019 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q1 2019 Earnings CallWed, May 01, 2019 · 4:30 PM ETReplay
DexCom (NASDAQ:DXCM) Q4 2018 Earnings CallThu, Feb 21, 2019 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 29, 2026 · After close+3.0%
Q2 2026Jul 30, 2026 · After close+11.9%
Q1 2026Apr 30, 2026 · After close+3.0%
Q4 2025Feb 12, 2026 · After close+7.6%
Q3 2025Oct 30, 2025 · After close−14.6%
Q2 2025Jul 30, 2025 · After close−9.3%
Q1 2025May 1, 2025 · After close+16.2%
Q4 2024Feb 13, 2025 · After close+5.9%
Q3 2024Oct 24, 2024 · After close−1.9%
Q2 2024Jul 25, 2024 · After close−40.7%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 25, 2024 · After close−9.9%
Q4 2023Feb 8, 2024 · After close−5.2%
Q3 2023Oct 26, 2023 · After close+10.1%
Q2 2023Jul 27, 2023 · After close+2.3%
Q1 2023Apr 27, 2023 · After close−1.8%
Q4 2022Feb 9, 2023 · After close+9.9%
Q3 2022Oct 27, 2022 · After close+19.4%
Q2 2022Jul 28, 2022 · After close−5.6%
Q1 2022Apr 28, 2022 · After close−1.1%
Q4 2021Feb 10, 2022 · After close−4.9%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings10 slidesOct 29, 2026
Q2 2026 Earnings PresentationEarnings10 slidesJul 30, 2026
Q2 2026 Earnings PresentationEarnings94 slidesJul 30, 2026
Q1 2026 Earnings PresentationEarnings10 slidesApr 30, 2026
Q4 2025 Earnings PresentationEarnings10 slidesFeb 12, 2026
Q4 2025 Earnings PresentationEarnings25 slidesFeb 12, 2026
Q3 2025 Earnings PresentationEarnings11 slidesOct 30, 2025
Investor Presentation (October 2025)Investor deck30 slidesOctober 2025
Q2 2025 Earnings PresentationEarnings11 slidesJul 30, 2025
Investor Presentation (July 2025)Investor deck29 slidesJuly 2025
All 45 decks
DeckKindSlidesDate
Investor Presentation (May 2025)Investor deck29 slidesMay 2025
Q1 2025 Earnings PresentationEarnings11 slidesMay 1, 2025
Raymond James Institutional Investors Conference 2025Conference30 slidesMarch 2025
Q4 2024 Earnings PresentationEarnings11 slidesFeb 13, 2025
J.P. Morgan Healthcare Conference 2025Conference30 slidesJan 13, 2025
Investor Presentation (November 2024)Investor deck23 slidesNovember 2024
Q3 2024 Earnings PresentationEarnings11 slidesOct 24, 2024
Investor Presentation (October 2024)Investor deck23 slidesOctober 2024
Q2 2024 Earnings PresentationEarnings11 slidesJul 25, 2024
Investor Presentation (July 2024)Investor deck24 slidesJuly 2024
Investor Presentation (July 2024)Investor deck36 slidesJuly 2024
William Blair Growth Stock Conference 2024Conference26 slidesJune 2024
Q1 2024 Earnings PresentationEarnings11 slidesApr 25, 2024
Investor Presentation (April 2024)Investor deck26 slidesApril 2024
Raymond James Institutional Investors Conference 2024Conference26 slidesMarch 2024
Q4 2023 Earnings PresentationEarnings11 slidesFeb 8, 2024
Investor Presentation (February 2024)Investor deck26 slidesFebruary 2024
J.P. Morgan Healthcare Conference 2024Conference26 slidesJan 8, 2024
Investor Presentation (November 2023)Investor deck26 slidesNovember 2023
Q3 2023 Earnings PresentationEarnings11 slidesOct 26, 2023
Investor Presentation (October 2023)Investor deck25 slidesOctober 2023
Investor Presentation (September 2023)Investor deck25 slidesSeptember 2023
Q2 2023 Earnings PresentationEarnings11 slidesJul 27, 2023
Investor Day (June 2023)Investor day74 slidesJun 23, 2023
Q1 2023 Earnings PresentationEarnings11 slidesApr 27, 2023
Investor Presentation (April 2023)Investor deck25 slidesApril 2023
Q4 2022 Earnings PresentationEarnings12 slidesFeb 9, 2023
41st Annual J.P. Morgan Healthcare Conference (January 2023)Conference25 slidesJan 9, 2023
Q3 2022 Earnings PresentationEarnings12 slidesOct 27, 2022
Investor Presentation (October 2022)Investor deck24 slidesOctober 2022
Investor Presentation (August 2022)Investor deck25 slidesAugust 2022
Q2 2022 Earnings PresentationEarnings12 slidesJul 28, 2022
J.P. Morgan Healthcare Conference 2022Conference25 slidesJan 10, 2022
JP Morgan Healthcare Conference 2018Conference26 slidesJan 9, 2018
Technical Presentation (2013)Technical38 slides2013

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue4.66B4.03B3.62B2.91B2.45B1.93B1.48B1.03B718.5M573.3M
Cost of revenue1.86B1.59B1.33B1.03B768.0M646.6M544.5M367.7M226.4M194.9M
Gross profit2.80B2.44B2.29B1.88B1.68B1.28B931.5M663.9M492.1M378.4M
Research and development599.1M552.4M505.8M484.2M517.1M359.9M273.5M199.7M185.4M156.1M
Selling, general and administrative1.29B1.29B1.19B1.01B810.5M618.2M515.7M432.8M349.2M286.2M
Operating income911.8M600.0M597.7M391.2M265.8M299.5M142.3M-186.3M-42.5M-63.9M
Depreciation and amortization251.8M217.7M186.0M155.9M102.0M67.1M48.7M29.1M16.1M15.0M
EBITDA1.16B817.7M783.7M547.1M367.8M366.6M191.0M-157.2M-26.4M-48.9M
Interest expense18.3M19.0M20.3M18.6M18.8M17.7M60.3M22.7M12.8M700.0K
Income before tax1.09B709.0M710.4M390.8M256.8M297.9M104.2M-126.5M-48.6M-64.9M
Income tax252.1M132.8M168.9M49.6M39.9M-251.8M3.10M600.0K1.60M700.0K
Net income836.3M576.2M541.5M341.2M216.9M549.7M101.1M-127.1M-50.2M-65.6M
Earnings per share, basic2.141.461.400.880.561.461.11-1.44-0.58-0.78
Earnings per share, diluted2.091.421.300.820.531.331.10-1.44-0.58-0.78

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents917.7M606.1M566.3M642.3M1.05B817.6M446.2M1.14B441.5M94.5M
Short-term investments1.73B2.16B1.81B1.36B92.7M107.1M29.2M
Receivables1.22B1.01B973.9M713.3M514.3M428.5M286.3M226.7M134.3M101.7M
Inventory629.1M542.6M559.6M306.7M357.3M234.7M119.8M70.7M45.2M45.4M
Current assets4.03B4.30B4.43B3.67B3.68B3.42B1.97B1.70B744.7M280.0M
Property, plant and equipment1.06B801.8M515.3M321.3M183.1M145.6M109.4M
Goodwill24.2M22.8M25.2M25.7M26.5M19.3M18.6M18.7M12.1M11.3M
Total assets6.34B6.48B6.26B5.39B4.93B4.29B2.40B1.92B904.1M402.8M
Current liabilities2.14B2.93B1.56B1.84B720.8M614.1M360.2M222.4M138.9M102.4M
Total liabilities3.59B4.38B4.20B3.26B2.89B2.46B1.51B1.25B484.7M119.0M
Shareholders' equity2.75B2.10B2.07B2.13B2.04B1.55B882.6M663.3M419.4M283.8M
Shares outstanding384.8M390.7M385.4M386.3M388.0M96.1M91.6M90.0M87.0M84.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations1.44B989.5M748.5M669.5M442.5M475.6M314.5M123.2M92.0M56.2M
Capital spending-363.5M-358.8M-236.6M-364.8M-389.2M-199.0M-180.0M-67.1M-66.0M-55.7M
Free cash flow1.08B630.7M511.9M304.7M53.3M276.6M134.5M56.1M26.0M500.0K
Cash from investing536.0M-207.5M-507.2M-521.5M-216.1M-1.02B-1.02B-139.8M-144.4M-55.9M
Cash from financing-1.69B-734.8M-318.6M-552.5M10.4M912.1M10.7M710.4M399.1M8.10M
Share buybacks-500.0M-750.0M-688.7M-557.7M000-100.0M00
Change in cash311.8M39.8M-75.8M-410.3M235.4M371.8M-690.7M695.6M347.0M8.40M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 18, 2026Insider tradeSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
4 · Change in ownershipNov 10, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
4 · Change in ownershipNov 3, 2026Insider tradeSEC
10-Q · Quarterly reportOct 29, 2026Quarterly reportSEC
8-K · Current reportOct 29, 2026ResultsSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipOct 28, 2026Insider tradeSEC
144 · Notice of proposed saleOct 27, 2026Other filingsSEC
4 · Change in ownershipOct 19, 2026Insider tradeSEC
144 · Notice of proposed saleOct 15, 2026Other filingsSEC
4 · Change in ownershipSep 30, 2026Insider tradeSEC
144 · Notice of proposed saleSep 28, 2026Other filingsSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
144 · Notice of proposed saleSep 15, 2026Other filingsSEC
144 · Notice of proposed saleSep 15, 2026Other filingsSEC
8-K · Current reportSep 14, 2026Management or board changeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
144 · Notice of proposed saleSep 14, 2026Other filingsSEC
4 · Change in ownershipSep 10, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 10, 2026Insider tradeSEC
8-K · Current reportSep 10, 2026Management or board changeSEC
144 · Notice of proposed saleSep 10, 2026Other filingsSEC
4 · Change in ownershipAug 28, 2026Insider tradeSEC
144 · Notice of proposed saleAug 27, 2026Other filingsSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 25, 2026Insider tradeSEC
4 · Change in ownershipAug 24, 2026Insider tradeSEC
144 · Notice of proposed saleAug 20, 2026Other filingsSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
144 · Notice of proposed saleAug 14, 2026Other filingsSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
144 · Notice of proposed saleAug 12, 2026Other filingsSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
144 · Notice of proposed saleJul 31, 2026Other filingsSEC
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
8-K · Current reportJul 30, 2026ResultsSEC
4 · Change in ownershipJul 21, 2026Insider tradeSEC
144 · Notice of proposed saleJul 20, 2026Other filingsSEC
4 · Change in ownershipJul 16, 2026Insider tradeSEC
144 · Notice of proposed saleJul 15, 2026Other filingsSEC
4 · Change in ownershipJul 7, 2026Insider tradeSEC
144 · Notice of proposed saleJul 6, 2026Other filingsSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
4 · Change in ownershipJun 5, 2026Insider tradeSEC
144 · Notice of proposed saleJun 4, 2026Other filingsSEC
144 · Notice of proposed saleJun 3, 2026Other filingsSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
8-K · Current reportMay 28, 2026Meeting outcomeSEC
SD · Specialized disclosureMay 28, 2026ESG reportSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
144 · Notice of proposed saleMay 21, 2026Other filingsSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
144 · Notice of proposed saleMay 15, 2026Other filingsSEC
8-K · Current reportMay 14, 2026Current reportSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
144 · Notice of proposed saleMay 12, 2026Other filingsSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
4 · Change in ownershipMay 11, 2026Insider tradeSEC
10-Q · Quarterly reportApr 30, 2026Quarterly reportSEC
8-K · Current reportApr 30, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 15, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 15, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 15, 2026Meeting noticeSEC
144 · Notice of proposed saleApr 15, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 18, 2026Insider tradeSEC
144 · Notice of proposed saleMar 16, 2026Other filingsSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
8-K · Current reportMar 2, 2026Management or board changeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 26, 2026Insider tradeSEC
8-K · Current reportFeb 26, 2026Management or board changeSEC
4 · Change in ownershipFeb 17, 2026Insider tradeSEC
10-K · Annual reportFeb 12, 2026Annual reportSEC
8-K · Current reportFeb 12, 2026ResultsSEC
144 · Notice of proposed saleFeb 12, 2026Other filingsSEC
4 · Change in ownershipFeb 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 2, 2026Insider tradeSEC
4 · Change in ownershipFeb 2, 2026Insider tradeSEC
8-K · Current reportJan 12, 2026ResultsSEC
8-K · Current reportDec 22, 2025Management or board changeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
144 · Notice of proposed saleNov 14, 2025Other filingsSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
144 · Notice of proposed saleNov 10, 2025Other filingsSEC
10-Q · Quarterly reportOct 30, 2025Quarterly reportSEC
8-K · Current reportOct 30, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 30, 2025Big-stake noticeSEC
4 · Change in ownershipOct 28, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 28, 2025Insider tradeSEC
8-K · Current reportOct 27, 2025Management or board changeSEC
8-K · Current reportSep 15, 2025Management or board changeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 8, 2025Insider tradeSEC
144 · Notice of proposed saleSep 5, 2025Other filingsSEC
144 · Notice of proposed saleSep 4, 2025Other filingsSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
144 · Notice of proposed saleSep 2, 2025Other filingsSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
144 · Notice of proposed saleAug 15, 2025Other filingsSEC
144 · Notice of proposed saleAug 15, 2025Other filingsSEC
10-Q · Quarterly reportJul 30, 2025Quarterly reportSEC
8-K · Current reportJul 30, 2025ResultsSEC
4 · Change in ownershipJul 29, 2025Insider tradeSEC
144 · Notice of proposed saleJul 28, 2025Other filingsSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
144 · Notice of proposed saleJul 15, 2025Other filingsSEC
144 · Notice of proposed saleJul 15, 2025Other filingsSEC
4/A · Change in ownership, amendedJul 7, 2025Insider tradeSEC
4 · Change in ownershipJun 30, 2025Insider tradeSEC
144 · Notice of proposed saleJun 26, 2025Other filingsSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
4 · Change in ownershipJun 17, 2025Insider tradeSEC
144 · Notice of proposed saleJun 16, 2025Other filingsSEC
144 · Notice of proposed saleJun 16, 2025Other filingsSEC
144 · Notice of proposed saleJun 9, 2025Other filingsSEC
SD · Specialized disclosureMay 29, 2025ESG reportSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
4 · Change in ownershipMay 28, 2025Insider tradeSEC
144 · Notice of proposed saleMay 27, 2025Other filingsSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
144 · Notice of proposed saleMay 23, 2025Other filingsSEC
8-K · Current reportMay 13, 2025Management or board changeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
8-K/A · Current report, amendedMay 9, 2025Management or board changeSEC
S-8 · Registration statement for employee plansMay 9, 2025Offer documentSEC
8-K · Current reportMay 9, 2025Management or board changeSEC
DEFA14A · Additional proxy materialMay 2, 2025Meeting noticeSEC
8-K · Current reportMay 2, 2025Management or board changeSEC
10-Q · Quarterly reportMay 1, 2025Quarterly reportSEC
8-K · Current reportMay 1, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 24, 2025Big-stake noticeSEC
3 · Initial statement of ownershipMar 31, 2025Insider tradeSEC
ARS · Annual report to shareholdersMar 27, 2025Annual reportSEC
DEFA14A · Additional proxy materialMar 27, 2025Meeting noticeSEC
DEF 14A · Proxy statementMar 27, 2025Meeting noticeSEC
8-K · Current reportMar 25, 2025Current reportSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
144 · Notice of proposed saleMar 17, 2025Other filingsSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC
4 · Change in ownershipMar 11, 2025Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from DexCom, Inc.’s releases · as of Oct 22, 2026

Common shares
372,950,922
Fully diluted
372,950,922

Fully diluted

LineSharesAs of
Common shares372,950,922Oct 22, 2026

Share count over time

CountShares
Oct 22, 2026372,950,922

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard48.5M13.0%US$4.19BSep 30, 2026
BlackRock38.5M10.3%US$3.32BSep 30, 2026
State Street18.9M5.1%US$1.63BSep 30, 2026
Invesco16M4.3%US$1.38BSep 30, 2026
Baillie Gifford & Co14.5M3.9%US$1.25BSep 30, 2026
UBS12.7M3.4%US$1.1BSep 30, 2026
Geode Capital12.5M3.3%US$1.07BSep 30, 2026
Arrowstreet Capital, Limited Partnership7.83M2.1%US$675MSep 30, 2026
Wellington5.19M1.4%US$447MSep 30, 2026
Schroders5.18M1.4%US$447MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Morgan Stanley5.13M1.4%US$442MSep 30, 2026
Franklin Templeton5.11M1.4%US$453MSep 30, 2026
Amundi4.77M1.3%US$411MSep 30, 2026
Sun Life4.61M1.2%US$400MSep 30, 2026
Bank of America4.51M1.2%US$389MSep 30, 2026
Nuveen4.41M1.2%US$381MSep 30, 2026
Citadel4.14M1.1%US$357MSep 30, 2026
BNP Paribas4.1M1.1%US$354MSep 30, 2026
Ameriprise4.1M1.1%US$354MSep 30, 2026
Castle Hook Partners LP3.85M1.0%US$332MSep 30, 2026
JPMorgan3.74M1.0%US$324MSep 30, 2026
Goldman Sachs3.58M0.96%US$309MSep 30, 2026
CIBC3.47M0.93%US$299MSep 30, 2026
American Century3.47M0.93%US$299MSep 30, 2026
Northern Trust3.35M0.90%US$289MSep 30, 2026
Raymond James Financial Inc3.16M0.85%US$273MSep 30, 2026
T. Rowe Price2.91M0.78%US$251MSep 30, 2026
AQR Capital Management LLC2.82M0.76%US$241MSep 30, 2026
Legal & General2.77M0.74%US$239MSep 30, 2026
Schwab2.72M0.73%US$235MSep 30, 2026
BNY2.41M0.65%US$208MSep 30, 2026
AllianceBernstein2.37M0.63%US$204MSep 30, 2026
Renaissance Technologies2.35M0.63%US$202MSep 30, 2026
RBC2.34M0.63%US$202MSep 30, 2026
Fidelity2.3M0.62%US$198MSep 30, 2026
Capital Group2.26M0.61%US$195MSep 30, 2026
Dimensional2.2M0.59%US$190MSep 30, 2026
Employees Provident Fund Board2.19M0.59%US$189MSep 30, 2026
DWS2.09M0.56%US$180MSep 30, 2026
MUFG1.89M0.51%US$163MSep 30, 2026
Susquehanna1.6M0.43%US$138MSep 30, 2026
Blair William & Co1.55M0.42%US$134MSep 30, 2026
Victory Capital1.32M0.35%US$114MSep 30, 2026
Stephens Investment Management Group LLC1.27M0.34%US$110MSep 30, 2026
Dsm Capital Partners LLC1.25M0.33%US$107MSep 30, 2026
Swedbank AB1.18M0.32%US$102MSep 30, 2026
Barclays1.18M0.32%US$102MSep 30, 2026
Thrivent Financial for Lutherans1.15M0.31%US$99.2MSep 30, 2026
Blue Sparrow, LLC1.09M0.29%US$94.2MSep 30, 2026
Janus Henderson1.07M0.29%US$92.1MSep 30, 2026

This page holds 50 of 1,029 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund12.3M3.3%US$825MJun 30, 2026
Vanguard 500 Index Fund10M2.7%US$674MJun 30, 2026
Vanguard Mid-Cap Index Fund8.36M2.2%US$563MJun 30, 2026
Invesco QQQ Trust, Series 18.19M2.2%US$552MJun 30, 2026
Vanguard Health Care Fund5.38M1.4%US$449MJul 31, 2026
iShares Core S&P 500 ETF5.31M1.4%US$358MJun 30, 2026
Vanguard Growth Index Fund4.95M1.3%US$333MJun 30, 2026
Fidelity 500 Index Fund4.93M1.3%US$363MMay 31, 2026
Vanguard Mid-Cap Growth Index Fund2.96M0.79%US$199MJun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF2.73M0.73%US$184MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Invesco S&P 500 Equal Weight ETF2.49M0.67%US$208MJul 31, 2026
iShares Russell Mid-Cap Growth ETF2.26M0.61%US$152MJun 30, 2026
Vanguard Institutional Index Fund2.1M0.56%US$141MJun 30, 2026
AB Large Cap Growth Fund Inc1.87M0.50%US$126MJun 30, 2026
iShares U.S. Medical Devices ETF1.81M0.48%US$122MJun 30, 2026
Invesco NASDAQ 100 ETF1.64M0.44%US$121MMay 31, 2026
iShares Russell Mid-Cap ETF1.58M0.42%US$106MJun 30, 2026
iShares Russell 1000 Growth ETF1.47M0.39%US$98.7MJun 30, 2026
Fidelity Mid Cap Index Fund1.45M0.39%US$121MJul 31, 2026
Fidelity SAI U.S. Quality Index Fund1.33M0.36%US$111MJul 31, 2026
Vanguard Health Care Index Fund1.17M0.31%US$86.4MMay 31, 2026
Pacer US Cash Cows 100 ETF1.1M0.29%US$91.6MJul 31, 2026
Invesco S&P 500 Quality ETF1.07M0.29%US$89.3MJul 31, 2026
MFS Mid Cap Growth Fund1.06M0.29%US$78.4MMay 31, 2026
Franklin Small-Mid Cap Growth Fund1.06M0.28%US$88.5MJul 31, 2026
Heritage Fund1.04M0.28%US$86.5MJul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF919K0.25%US$61.9MJun 30, 2026
JPMorgan Nasdaq Equity Premium Income ETF885K0.24%US$59.6MJun 30, 2026
Schwab S&P 500 Index Fund858K0.23%US$71.6MJul 31, 2026
Schwab U.S. Large-Cap Growth ETF821K0.22%US$60.6MMay 31, 2026
Fidelity Total Market Index Fund728K0.20%US$53.7MMay 31, 2026
Elfun Trusts710K0.19%US$47.8MJun 30, 2026
BlackRock Health Sciences Opportunities Portfolio664K0.18%US$48.9MMay 29, 2026
Carillon Eagle Mid Cap Growth Fund660K0.18%US$44.4MJun 30, 2026
iShares MSCI USA Quality Factor ETF659K0.18%US$55MJul 31, 2026
Vanguard Russell 1000 Growth Index Fund646K0.17%US$47.6MMay 31, 2026
Vanguard Explorer Fund634K0.17%US$52.9MJul 31, 2026
American Funds Fundamental Investors622K0.17%US$41.9MJun 30, 2026
Thrivent Mid Cap Stock Fund620K0.17%US$51.7MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account616K0.17%US$41.5MJun 30, 2026
Fidelity Series Total Market Index Fund587K0.16%US$43.3MMay 31, 2026
Nomura Mid Cap Growth Fund576K0.15%US$38.8MJun 30, 2026
Avantis U.S. Large Cap Value ETF558K0.15%US$41.2MMay 31, 2026
Transamerica WMC US Growth VP531K0.14%US$35.7MJun 30, 2026
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.509K0.14%US$34.3MJun 30, 2026
Fidelity Large Cap Growth Index Fund505K0.14%US$42.2MJul 31, 2026
Dimensional U.S. Core Equity 2 ETF499K0.13%US$41.7MJul 31, 2026
Franklin Growth Opportunities Fund497K0.13%US$41.4MJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF496K0.13%US$33.4MJun 30, 2026
First Trust Nasdaq-100 Select Equal Weight ETF482K0.13%US$32.5MJun 30, 2026

This page holds 50 of 861 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Brown Michael Jon
Officer: EVP Chief Legal Compliance Off
Sale1,700USD 83.46US$142KNov 16, 2026
Stern Sadie
Officer: EVP Chief People & Culture Off
Sale2,565USD 78.62US$202KOct 27, 2026
Brown Michael Jon
Officer: EVP Chief Legal Compliance Off
Sale1,700USD 85.48US$145KOct 15, 2026
Stern Sadie
Officer: EVP Chief People & Culture Off
Sale2,565USD 86.15US$221KSep 28, 2026
Brown Michael Jon
Officer: EVP Chief Legal Compliance Off
Sale1,700USD 84.04US$143KSep 15, 2026
Augustinos Nicholas
Director
Sale6,539USD 84.04US$550KSep 15, 2026
Augustinos Nicholas
Director
Sale1,550USD 84.02US$130KSep 14, 2026
Sylvain Jereme M
Officer: EVP, Chief Financal Officer
Sale3,638USD 83.27US$303KSep 10, 2026
Stern Sadie
Officer: EVP Chief People & Culture Off
Sale2,565USD 88.37US$227KAug 27, 2026
Sayer Kevin R
Director, Officer: Executive Chair
Sale19,308USD 89.71US$1.73MAug 20, 2026
All 28 trades
TradeTradeSharesPriceValueDate
Sayer Kevin R
Director, Officer: Executive Chair
Sale7,351USD 90.78US$667KAug 20, 2026
Sayer Kevin R
Director, Officer: Executive Chair
Sale97USD 91.41US$8,867Aug 20, 2026
Brown Michael Jon
Officer: EVP Chief Legal Compliance Off
Sale1,700USD 91.93US$156KAug 14, 2026
Heller Bridgette P
Director
Sale1,012USD 88.29US$89,349Aug 12, 2026
Foletta Mark G
Director
Sale2,000USD 85.32US$171KAug 3, 2026
Foletta Mark G
Director
Sale2,000USD 80.00US$160KJul 31, 2026
Sayer Kevin R
Director, Officer: Executive Chair
Sale26,756USD 76.32US$2.04MJul 20, 2026
Brown Michael Jon
Officer: EVP Chief Legal Compliance Off
Sale1,700USD 74.42US$127KJul 15, 2026
Sayer Kevin R
Director, Officer: Executive Chair
Sale26,756USD 72.00US$1.93MJul 6, 2026
Foletta Mark G
Director
Sale3,801USD 74.10US$282KJun 15, 2026
Foletta Mark G
Director
Sale199USD 74.82US$14,889Jun 15, 2026
Brown Michael Jon
Officer: EVP Chief Legal Compliance Off
Sale1,700USD 75.55US$128KJun 15, 2026
Coleman Jon
Officer: EVP, Chief Commercial Officer
Sale4,911USD 74.13US$364KJun 4, 2026
Coleman Jon
Officer: EVP, Chief Commercial Officer
Sale4,912USD 73.00US$359KJun 3, 2026
Sayer Kevin R
Director, Officer: Executive Chair
Sale26,759USD 72.00US$1.93MMay 21, 2026
Brown Michael Jon
Officer: EVP, Chief Legal Officer
Sale1,700USD 59.91US$102KMay 15, 2026
Heller Bridgette P
Director
Sale1,012USD 60.01US$60,730May 12, 2026
Brown Michael Jon
Officer: EVP, Chief Legal Officer
Sale1,700USD 63.04US$107KApr 15, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.8.30%32.5MMar 31, 2025Schedule 13G
Vanguard Capital Management LLC7.49%28.8MMar 31, 2026Schedule 13G
Vanguard Portfolio Management LLC5.02%19.3MMar 31, 2026Schedule 13G
State Street Corp5.00%18.9MSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Quentin Blackford
Other companies: Align Technology, Inc. (Director · Since at least Aug 27, 2026); iRhythm Holdings, Inc. (President, Chief Executive Officer and Director · Since at least Oct 4, 2021); Alphatec Holdings, Inc. (Director · Since at least Oct 2, 2017); Paragon 28 Inc (Director · Aug 1, 2022 – Apr 21, 2025 · Past); Axogen, Inc. (Director · Apr 26, 2019 – Mar 30, 2022 · Past); NuVasive Inc (CFO · Jul 1, 2016 – Feb 8, 2017 · Past)
Chief Operating Officer · Sep 7, 2017 – Sep 8, 2021 · Past
Bridgette Heller
Other companies: Integral Ad Science Holding LLC (Director · Since at least Jun 29, 2021); Aramark (Director · Since at least Feb 2, 2021); Tech Data Corporation (Director · Nov 29, 2016 – Jun 30, 2020 · Past); ADT Inc. (Director · Sep 28, 2012 – May 2, 2016 · Past); Merck & Company, Inc. (Exe.VP & Pres.Con.Hlth.Care · Mar 1, 2010 – May 9, 2014 · Past)
Director · Since at least Sep 13, 2019
Mark Foletta
Other companies: Enanta Pharmaceuticals, Inc. (Director · Since at least Jun 29, 2020); AMN Healthcare Services Inc (Director · Since at least Nov 27, 2017); Tocagen Inc (EVP & Chief Financial Officer · Dec 8, 2017 – Oct 4, 2019 · Past); Regulus Therapeutics Inc (Director · Dec 4, 2017 – Dec 4, 2017 · Past)
Director · Since at least Nov 27, 2017
Renée Galá
Other companies: Jazz Pharmaceuticals plc (President & CEO, Director · Since at least Mar 16, 2020); Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 8, 2023 · Past); Corcept Therapeutics Incorporated (Director · Mar 6, 2018 – Aug 20, 2018 · Past); Theravance Biopharma, Inc. (SVP, Chief Financial Officer · Nov 20, 2017 – Nov 20, 2018 · Past)
Director · Since at least Mar 6, 2025
Sean Carney
Other companies: Beta Bionics, Inc. (Board Member · Since at least Jan 29, 2025); MBIA Inc. (Director · Dec 12, 2013 – Jan 4, 2016 · Past); Wright Medical Group N.V (Director · Feb 2, 2011 – Mar 31, 2017 · Past); Arch Capital Group Ltd. (Director · May 3, 2006 – May 5, 2010 · Past)
Director · Jan 3, 2006 – May 19, 2008 · Past
Donald L Lucas
Other companies: Spansion Inc (Director · Sep 20, 2007 – Aug 27, 2009 · Past); Cadence Design Systems, Inc. (Director · Apr 1, 2006 – Apr 2, 2012 · Past); Oracle Corporation (Director · Jan 31, 2006 – Jan 31, 2013 · Past)
Director · Jan 4, 2006 – Mar 15, 2010 · Past
Glenn Boehnlein
Other companies: Agilent Technologies, Inc. (Director · Since at least Sep 4, 2026); Inogen, Inc (Director · Since at least Mar 22, 2022); Stryker Corporation (VP, Chief Financial Officer · Apr 1, 2016 – Mar 21, 2025 · Past)
Director · Since at least Sep 10, 2026
Heather S Ace
Other companies: PENN Entertainment, Inc. (Director · Since at least Feb 22, 2026); QUALCOMM Incorporated (EVP, Chief HR Officer · Since at least Mar 23, 2020)
SVP Human Resources · Aug 23, 2019 – Mar 11, 2020 · Past
Karen M Dahut
Other companies: Tech Data Corporation (Director · Jun 6, 2018 – Jun 30, 2020 · Past); Booz Allen Hamilton Holding Corporation (Executive Vice President · Oct 3, 2017 – Jun 30, 2022 · Past)
Director · Aug 11, 2020 – May 8, 2025 · Past
Steven J Kemper
Other companies: Constellation Alpha Capital Corp (Chief Financial Officer · Aug 29, 2019 – Aug 29, 2019 · Past); GenMark Diagnostics Inc (CFO, Treasurer & Secretary · May 28, 2010 – Sep 8, 2010 · Past)
Chief Financial Officer · Jan 5, 2006 – May 15, 2007 · Past
All 49 people
PersonSeat
Teri Lawver
Other companies: Celldex Therapeutics, Inc. (Senior Vice President, Chief Commercial Officer · Since at least Nov 10, 2025); Altimmune, Inc. (Director · Since at least Feb 24, 2025)
EVP Chief Commercial Officer · Jan 9, 2023 – Mar 12, 2024 · Past
Andrew K Balo
Other companies: GlucoTrack, Inc. (Director · Jun 14, 2024 – Mar 26, 2025 · Past)
EVP Regulatory Strategy Clinic · May 2, 2006 – Mar 10, 2023 · Past
Andrew P Rasdal
Other companies: Vyome Holdings, Inc. (President, CEO & Exec Chairman, Director · Oct 5, 2016 – Jun 23, 2020 · Past)
President & CEO · May 2, 2006 – May 2, 2006 · Past
Chad Patterson
Other companies: iRhythm Holdings, Inc. (Chief Commercial and Product Officer · Since at least Jul 25, 2022)
EVP Global Marketing · Mar 31, 2021 – May 9, 2022 · Past
Donald Abbey
Other companies: ICU Medical, Inc. (Independent Director · Since at least May 15, 2019)
EVP Global Business Services I · Jun 3, 2019 – Mar 10, 2023 · Past
Euan Ashley
Other companies: AstraZeneca PLC (Non-Executive Director · Since at least Nov 5, 2026)
Director · Since at least Oct 24, 2025
Jacob Leach
Other companies: SenesTech, Inc. (Director · Since at least Jul 1, 2022)
President & Chief Executive Officer · Since at least Mar 6, 2023
Jereme Sylvain
Other companies: NuVasive Inc (Chief Accounting Officer · Aug 1, 2016 – Feb 1, 2018 · Past)
EVP, Chief Operating Officer and Chief Financial Officer · Since at least Mar 6, 2020
Jess Roper
Other companies: Revelation Biosciences, Inc. (Director · Since at least Jan 10, 2022)
Former SVP, CFO · Jul 31, 2007 – Apr 1, 2017 · Past
John Lister
Other companies: BillionToOne, Inc. (Chief Administrative Officer · Since at least Nov 5, 2025)
General Manager, EMEA · Mar 8, 2011 – Mar 8, 2017 · Past
Jon Coleman
Other companies: Masimo Corporation (Pres-WW OEM & Global Health · Aug 11, 2008 – Feb 26, 2021 · Past)
EVP, Chief Commercial Officer · Since at least Mar 31, 2025
Kyle Malady
Other companies: Verizon Communications Inc. (Executive Vice President and CEO Verizon Business Group · Since at least Oct 1, 2020)
Director · Since at least Oct 11, 2020
Rimma Driscoll
Other companies: Zoetis Inc. (Executive Vice President, Global Strategy, Portfolio Marketing, Business Development, Human Health and Platinum Performance · Since at least Nov 1, 2022)
Director · Since at least Aug 24, 2023
Steven Robert Pacelli
Other companies: ProSomnus, Inc. (Director · Dec 6, 2022 – Feb 16, 2024 · Past)
EVP Managing Director Dexcom V · Apr 25, 2022 – Nov 24, 2023 · Past
Terrance H Gregg
Other companies: Amylin Pharmaceuticals LLC (Director · Dec 31, 2005 – Apr 5, 2006 · Past)
Former Executive Chairman, Director · Jan 3, 2006 – Jul 30, 2018 · Past
Albert Frederick Osterloh IVDirector · Since at least Feb 26, 2026
Barbara KahnDirector · May 18, 2024 – May 18, 2024 · Past
Eric TopolDirector · May 20, 2022 – May 8, 2025 · Past
Girish NaganathanEVP Chief Technology Officer · Oct 5, 2022 – Nov 9, 2023 · Past
James H BraukerVP Research & Development · Feb 1, 2006 – Mar 24, 2008 · Past
Jeffrey MoyEVP Operations · Mar 8, 2012 – Sep 9, 2020 · Past
Jon ColemanEVP, Chief Commercial Officer · Since at least Mar 25, 2025
Jorge A ValdesFormer CTO · Aug 2, 2007 – Mar 31, 2017 · Past
Kevin SayerChair · Since at least Jan 7, 2026
Laura JohnsonV.P., Intellectual Property · Sep 25, 2008 – Mar 12, 2010 · Past
Matthew DolanEVP, Strategy & Corporate Development · Since at least Mar 4, 2022
Michael BrownEVP, Chief Legal & Compliance Officer · Since at least Jan 26, 2022
Nicholas AugustinosDirector · Since at least May 19, 2010
Nick AugustinosDirector · Since at least Sep 16, 2026
Paul R FlynnEVP Global Revenue · Mar 31, 2021 – Dec 18, 2023 · Past
Peter SimpsonEVP, Chief Technology Officer · Since at least Nov 19, 2025
Richard CollinsDirector · Since at least Mar 9, 2017
Richard DoubledayEVP Chief Commercial Officer · Jun 22, 2009 – Mar 23, 2021 · Past
Rick OsterlohDirector · Since at least Feb 26, 2026
Sadie SternEVP, Chief People & Culture Officer · Since at least May 22, 2026
Sean ChristensenINVESTOR RELATIONS · Since at least Jul 30, 2026
Steven R AltmanDirector · Since at least May 8, 2025
Steven R. AltmanDirector · Since at least Jun 1, 2026
Tae AndrewsVice President of Marketing · Apr 3, 2006 – Mar 9, 2007 · Past

Open People

Log in to ask 6ix AI your own questions about DexCom, Inc.